Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).
Quick Stats
Feb 02, 202655.8
AI Score
HOLD2.5
Volume Ratio
Mar 10, 2026
Next Earnings
12
+ve Days (30d)
17
-ve Days (30d)
XLO Stock Summary
Last updated Feb 02, 2026
XLO is currently trading at $0.5876, positioned below its 200-day moving average of $0.73, suggesting bearish momentum. The stock has a 52-week range of $0.5351 to $1.7.
Technical Analysis: The 50-day moving average stands at $0.68, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 32.874, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.008, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates XLO at 55.8/100 with a HOLD recommendation.
XLO (Xilio Therapeutics, Inc. Common Stock) Indicators
Last updated Feb 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 32.874 |
| CMF (20) | -0.008 |
| ROC (10) | -8.202 |
| ADX (14) | 28.547 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.023 |
| AROONOSC (14) | -100.0 |
| WILLAMS %R (14) | -65.529 |
| MFI (14) | 10.633 |
XLO Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
XLO Price vs Max Options Open Interest
XLO Max Change In Options Open Interest
XLO Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
XLO Daily Out of Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
XLO Daily In the Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
XLO Most Active Options by Volume(near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Xilio Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
XLO Moving Averages Analysis
XLO (Xilio Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Feb 02, 2026
| Days | MA |
|---|---|
| 10 | 0.61 |
| 20 | 0.64 |
| 30 | 0.65 |
| 50 | 0.68 |
| 100 | 0.73 |
| 200 | 0.73 |
XLO Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 40.2 million |
| Earnings/Share ($) | -0.61 |
| Net Proft Margin (%) | -1.839 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.44 |
| EPS Estimate Next Year ($) | -0.18 |
| WallStreet Target Price ($) | 2 |
| Most Recent Quarter |